Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquis Exchange Regulatory News (AQX)

  • This share is currently suspended. It was suspended at a price of 725.00
  • There is currently no data for AQX

Form 8.3 - Aquis Exchange plc

1 Apr 2025 15:25

RNS Number : 0282D
Glazer Capital, LLC
01 April 2025
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

Glazer Capital, LLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Aquis Exchange plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

March 31, 2025

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

10p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 

 

(2) Derivatives (other than options):

725,186

2.63%

 

 

(3) Options and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

725,186

2.63%

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

10p ordinary

Total return equity swaps

Increasing a long position

23,500

7.08 GBP

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

April 1, 2025

Contact name:

Ava Lederer

Telephone number:

212-808-7306

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETWPUMUWUPAPGG
Date   Source Headline
4th Mar 20203:49 pmRNSFCA Approval of NEX Exchange Acquisition
19th Dec 20197:00 amRNSTiming of NEX Exchange Acquisition,Trading Update
22nd Nov 20192:40 pmRNSDirector/PDMR Notification
17th Sep 20197:00 amRNSInterim results for six months ended 30 June 2019
28th Aug 20197:00 amRNSNotice of Results
5th Jul 20197:00 amRNSAcquisition of NEX Exchange
27th Jun 20195:57 pmRNSMarket Update
5th Jun 20197:00 amRNSAquis Exchange achieves record market share
30th Apr 20191:16 pmRNSResult of AGM
29th Mar 20197:00 amRNSPublication of Annual Report and Notice of AGM
20th Mar 20191:30 pmRNSConfirmation of Board Appointment
20th Mar 20197:00 amRNSFinal Results for the year ended 31 December 2018
5th Mar 201911:00 amRNSAquis supplies AkinovA with trading technology
26th Feb 20194:38 pmRNSTR-1: Notification of major holdings
19th Feb 20197:00 amRNSTR-1: Notification of major holdings
24th Jan 20197:00 amRNSFrench Regulatory Approval
8th Jan 20197:00 amRNSTrading Update and Board Appointment
7th Jan 20192:14 pmRNSTR-1: Notification of major holdings
4th Dec 201811:13 amRNSAQUIS EXCHANGE RELEASE NOVEMBER TRADING STATISTICS
26th Nov 201811:10 amRNSStandard form for notification of major holdings
21st Nov 201810:17 amRNSDirector/PDMR Notification
16th Oct 20189:54 amRNSTR-1: Notification of major holdings
25th Sep 20187:00 amRNSInterim Results for six months ended 30 June 2018
6th Sep 20187:00 amRNSTechnology Licensing Agreement
4th Sep 20185:19 pmRNSResult of General Meeting
13th Aug 20185:15 pmRNSNotice of General Meeting
4th Jul 20183:59 pmRNSTR-1: Notification of major holdings
14th Jun 20188:30 amRNSDirector/PDMR Shareholding
14th Jun 20187:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.